カルシウムチャンネルブロッカーの世界市場レポート2020

• 英文タイトル：Global Calcium Channel Blocker Sales Market Report 2020

• レポートコード：20QY06-01446 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥592,000 (USD4,000)	▷ お問い合わせ
Multi User	￥888,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,184,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社の当調査資料では、カルシウムチャンネルブロッカーのグローバル市場について種類別（ジヒドロピリジン、ジルチアゼム、ベラパミル、その他）、用途別（高血圧、冠動脈疾患、不整脈、心筋症）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・カルシウムチャンネルブロッカー市場の概要 ・世界の主要地域別カルシウムチャンネルブロッカー市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のカルシウムチャンネルブロッカー市場規模2015-2026：種類別（ジヒドロピリジン、ジルチアゼム、ベラパミル、その他） ・世界のカルシウムチャンネルブロッカー市場規模2015-2026：用途別（高血圧、冠動脈疾患、不整脈、心筋症） ・カルシウムチャンネルブロッカーの北米市場規模2015-2020 ・カルシウムチャンネルブロッカーのヨーロッパ市場規模2015-2020 ・カルシウムチャンネルブロッカーの中国市場規模2015-2020 ・カルシウムチャンネルブロッカーの日本市場規模2015-2020 ・カルシウムチャンネルブロッカーの東南アジア市場規模2015-2020 ・カルシウムチャンネルブロッカーのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Pfizer、、Aventis、、Searle、、Bayer、、AstraZeneca、、Knoll Pharmaceuticals、、Wyeth-Ayerst、、AstraZeneca、、Novartis、、Sanofi、） ・カルシウムチャンネルブロッカーの製造コスト分析 ・販売チャネル、流通業者、顧客 ・カルシウムチャンネルブロッカーの市場動向・機会・課題 ・調査の結論

A recently published report by QY Research titled Global Calcium Channel Blocker Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Calcium Channel Blocker market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.

QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Report Overview:

Calcium channel blockers（CCBs） are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Calcium Channel Blocker market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Calcium Channel Blocker industry.

Based on our recent survey, we have several different scenarios about the Calcium Channel Blocker YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 74 million in 2019. The market size of Calcium Channel Blocker will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

QY Research report provides an overview and scope of the global Calcium Channel Blocker market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Calcium Channel Blocker market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.

QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Calcium Channel Blocker market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Calcium Channel Blocker market. The report also includes nautical information, where it shows Calcium Channel Blocker market product volume, utilization value, and production processes.

The research report also consists of a competitive landscape that describes the top players that are functioning in the global Calcium Channel Blocker market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Calcium Channel Blocker market.

The demand of Calcium Channel Blocker is concentrated in developed areas like USA and Europe. In 2016, the consumption of Calcium Channel Blocker in USA was 26.78%, ahead of other regions. Other regions also enjoy the major market share in global region.

Geographical Analysis:

Based on region, the global Calcium Channel Blocker market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.

Key Players:

The major players that are operating in the global Calcium Channel Blocker market are

Pfizer

Aventis

Searle

Bayer

AstraZeneca

Knoll Pharmaceuticals

Wyeth-Ayerst

AstraZeneca

Novartis

Sanofi

Segment by Type

Dihydropyridine

Diltiazem

Verapamil

Others

Segment by Application

Hypertension

Coronary Artery Disease

Arrhythmia

Cardiomyopathy

Competitive Landscape:

Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Calcium Channel Blocker market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.

The report covers the following objectives:

• Proliferation and maturation of trade in the global Calcium Channel Blocker market.

• The market share of the global Calcium Channel Blocker market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.

• Current and future market trends that are influencing the growth opportunities and growth rate of the global Calcium Channel Blocker market.

• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Calcium Channel Blocker market.

レポート目次

---

1 Calcium Channel Blocker Market Overview

1.1 Calcium Channel Blocker Product Scope

1.2 Calcium Channel Blocker Segment by Type

1.2.1 Global Calcium Channel Blocker Sales by Type (2020-2026)

1.2.2 Dihydropyridine

1.2.3 Diltiazem

1.2.4 Verapamil

1.2.5 Others

1.3 Calcium Channel Blocker Segment by Application

1.3.1 Global Calcium Channel Blocker Sales Comparison by Application (2020-2026)

1.3.2 Hypertension

1.3.3 Coronary Artery Disease

1.3.4 Arrhythmia

1.3.5 Cardiomyopathy

1.4 Calcium Channel Blocker Market Estimates and Forecasts (2015-2026)

1.4.1 Global Calcium Channel Blocker Sales Growth Rate (2015-2026)

1.4.2 Global Calcium Channel Blocker Revenue and Growth Rate (2015-2026)

1.4.3 Global Calcium Channel Blocker Price Trends (2015-2026)

1.5 Coronavirus Disease 2019 (Covid-19): Calcium Channel Blocker Industry Impact

1.5.1 How the Covid-19 is Affecting the Calcium Channel Blocker Industry

1.5.1.1 Calcium Channel Blocker Business Impact Assessment – Covid-19

1.5.1.2 Supply Chain Challenges

1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products

1.5.2 Market Trends and Calcium Channel Blocker Potential Opportunities in the COVID-19 Landscape

1.5.3 Measures / Proposal against Covid-19

1.5.3.1 Government Measures to Combat Covid-19 Impact

1.5.3.2 Proposal for Calcium Channel Blocker Players to Combat Covid-19 Impact

2 Calcium Channel Blocker Estimate and Forecast by Region

2.1 Global Calcium Channel Blocker Market Size by Region: 2015 VS 2020 VS 2026

2.2 Global Calcium Channel Blocker Retrospective Market Scenario by Region (2015-2020)

2.2.1 Global Calcium Channel Blocker Sales Market Share by Region (2015-2020)

2.2.2 Global Calcium Channel Blocker Revenue Market Share by Region (2015-2020)

2.3 Global Calcium Channel Blocker Market Estimates and Forecasts by Region (2021-2026)

2.3.1 Global Calcium Channel Blocker Sales Estimates and Forecasts by Region (2021-2026)

2.3.2 Global Calcium Channel Blocker Revenue Forecast by Region (2021-2026)

2.4 Geographic Market Analysis: Market Facts & Figures

2.4.1 United States Calcium Channel Blocker Estimates and Projections (2015-2026)

2.4.2 Europe Calcium Channel Blocker Estimates and Projections (2015-2026)

2.4.3 China Calcium Channel Blocker Estimates and Projections (2015-2026)

2.4.4 Japan Calcium Channel Blocker Estimates and Projections (2015-2026)

2.4.5 Southeast Asia Calcium Channel Blocker Estimates and Projections (2015-2026)

2.4.6 India Calcium Channel Blocker Estimates and Projections (2015-2026)

3 Global Calcium Channel Blocker Competition Landscape by Players

3.1 Global Top Calcium Channel Blocker Players by Sales (2015-2020)

3.2 Global Top Calcium Channel Blocker Players by Revenue (2015-2020)

3.3 Global Calcium Channel Blocker Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Calcium Channel Blocker as of 2019)

3.4 Global Calcium Channel Blocker Average Price by Company (2015-2020)

3.5 Manufacturers Calcium Channel Blocker Manufacturing Sites, Area Served, Product Type

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3.7 Primary Interviews with Key Calcium Channel Blocker Players (Opinion Leaders)

4 Global Calcium Channel Blocker Market Size by Type

4.1 Global Calcium Channel Blocker Historic Market Review by Type (2015-2020)

4.1.1 Global Calcium Channel Blocker Sales Market Share by Type (2015-2020)

4.1.2 Global Calcium Channel Blocker Revenue Market Share by Type (2015-2020)

4.1.3 Global Calcium Channel Blocker Price by Type (2014-2020)

4.2 Global Calcium Channel Blocker Market Estimates and Forecasts by Type (2021-2026)

4.2.1 Global Calcium Channel Blocker Sales Forecast by Type (2021-2026)

4.2.2 Global Calcium Channel Blocker Revenue Forecast by Type (2021-2026)

4.2.3 Global Calcium Channel Blocker Price Forecast by Type (2021-2026)

5 Global Calcium Channel Blocker Market Size by Application

5.1 Global Calcium Channel Blocker Historic Market Review by Application (2015-2020)

5.1.1 Global Calcium Channel Blocker Sales Market Share by Application (2015-2020)

5.1.2 Global Calcium Channel Blocker Revenue Market Share by Application (2015-2020)

5.1.3 Global Calcium Channel Blocker Price by Application (2015-2020)

5.2 Global Calcium Channel Blocker Market Estimates and Forecasts by Application (2021-2026)

5.2.1 Global Calcium Channel Blocker Sales Forecast by Application (2021-2026)

5.2.2 Global Calcium Channel Blocker Revenue Forecast by Application (2021-2026)

5.2.3 Global Calcium Channel Blocker Price Forecast by Application (2021-2026)

3 North America Calcium Channel Blocker Market Facts & Figures

3.2 North America Calcium Channel Blocker Sales Market Share by Company (2015-2020)

3.3 North America Calcium Channel Blocker Sales Market Share by Type (2015-2020)

3.4 North America Calcium Channel Blocker Sales Market Share by Application (2015-2020)

4 Europe Calcium Channel Blocker Market Facts & Figures

4.2 Europe Calcium Channel Blocker Sales Market Share by Company (2015-2020)

4.3 Europe Calcium Channel Blocker Sales Market Share by Type (2015-2020)

4.4 Europe Calcium Channel Blocker Sales Market Share by Application (2015-2020)

5 China Calcium Channel Blocker Market Facts & Figures

5.2 China Calcium Channel Blocker Sales Market Share by Company (2015-2020)

5.3 China Calcium Channel Blocker Sales Market Share by Type (2015-2020)

5.4 China Calcium Channel Blocker Sales Market Share by Application (2015-2020)

6 Japan Calcium Channel Blocker Market Facts & Figures

6.2 Japan Calcium Channel Blocker Sales Market Share by Company (2015-2020)

6.3 Japan Calcium Channel Blocker Sales Market Share by Type (2015-2020)

6.4 Japan Calcium Channel Blocker Sales Market Share by Application (2015-2020)

7 Southeast Asia Calcium Channel Blocker Market Facts & Figures

7.2 Southeast Asia Calcium Channel Blocker Sales Market Share by Company (2015-2020)

7.3 Southeast Asia Calcium Channel Blocker Sales Market Share by Type (2015-2020)

7.4 Southeast Asia Calcium Channel Blocker Sales Market Share by Application (2015-2020)

8 India Calcium Channel Blocker Market Facts & Figures

8.2 India Calcium Channel Blocker Sales Market Share by Company (2015-2020)

8.3 India Calcium Channel Blocker Sales Market Share by Type (2015-2020)

8.4 India Calcium Channel Blocker Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Calcium Channel Blocker Business

12.1 Pfizer

12.1.1 Pfizer Calcium Channel Blocker Corporation Information

12.1.2 Pfizer Calcium Channel Blocker Business Overview and Total Revenue

12.1.3 Pfizer Calcium Channel Blocker Sales, Revenue and Gross Margin (2015-2020)

12.1.4 Pfizer Calcium Channel Blocker Products Offered

12.1.5 Pfizer Recent Development

12.2 Aventis

12.2.1 Aventis Calcium Channel Blocker Corporation Information

12.2.2 Aventis Calcium Channel Blocker Business Overview and Total Revenue

12.2.3 Aventis Calcium Channel Blocker Sales, Revenue and Gross Margin (2015-2020)

12.2.4 Aventis Calcium Channel Blocker Products Offered

12.2.5 Aventis Recent Development

12.3 Searle

12.3.1 Searle Calcium Channel Blocker Corporation Information

12.3.2 Searle Calcium Channel Blocker Business Overview and Total Revenue

12.3.3 Searle Calcium Channel Blocker Sales, Revenue and Gross Margin (2015-2020)

12.3.4 Searle Calcium Channel Blocker Products Offered

12.3.5 Searle Recent Development

12.4 Bayer

12.4.1 Bayer Calcium Channel Blocker Corporation Information

12.4.2 Bayer Calcium Channel Blocker Business Overview and Total Revenue

12.4.3 Bayer Calcium Channel Blocker Sales, Revenue and Gross Margin (2015-2020)

12.4.4 Bayer Calcium Channel Blocker Products Offered

12.4.5 Bayer Recent Development

12.5 AstraZeneca

12.5.1 AstraZeneca Calcium Channel Blocker Corporation Information

12.5.2 AstraZeneca Calcium Channel Blocker Business Overview and Total Revenue

12.5.3 AstraZeneca Calcium Channel Blocker Sales, Revenue and Gross Margin (2015-2020)

12.5.4 AstraZeneca Calcium Channel Blocker Products Offered

12.5.5 AstraZeneca Recent Development

12.6 Knoll Pharmaceuticals

12.6.1 Knoll Pharmaceuticals Calcium Channel Blocker Corporation Information

12.6.2 Knoll Pharmaceuticals Calcium Channel Blocker Business Overview and Total Revenue

12.6.3 Knoll Pharmaceuticals Calcium Channel Blocker Sales, Revenue and Gross Margin (2015-2020)

12.6.4 Knoll Pharmaceuticals Calcium Channel Blocker Products Offered

12.6.5 Knoll Pharmaceuticals Recent Development

12.7 Wyeth-Ayerst

12.7.1 Wyeth-Ayerst Calcium Channel Blocker Corporation Information

12.7.2 Wyeth-Ayerst Calcium Channel Blocker Business Overview and Total Revenue

12.7.3 Wyeth-Ayerst Calcium Channel Blocker Sales, Revenue and Gross Margin (2015-2020)

12.7.4 Wyeth-Ayerst Calcium Channel Blocker Products Offered

12.7.5 Wyeth-Ayerst Recent Development

12.8 AstraZeneca

12.8.1 AstraZeneca Calcium Channel Blocker Corporation Information

12.8.2 AstraZeneca Calcium Channel Blocker Business Overview and Total Revenue

12.8.3 AstraZeneca Calcium Channel Blocker Sales, Revenue and Gross Margin (2015-2020)

12.8.4 AstraZeneca Calcium Channel Blocker Products Offered

12.8.5 AstraZeneca Recent Development

12.9 Novartis

12.9.1 Novartis Calcium Channel Blocker Corporation Information

12.9.2 Novartis Calcium Channel Blocker Business Overview and Total Revenue

12.9.3 Novartis Calcium Channel Blocker Sales, Revenue and Gross Margin (2015-2020)

12.9.4 Novartis Calcium Channel Blocker Products Offered

12.9.5 Novartis Recent Development

12.10 Sanofi

12.10.1 Sanofi Calcium Channel Blocker Corporation Information

12.10.2 Sanofi Calcium Channel Blocker Business Overview and Total Revenue

12.10.3 Sanofi Calcium Channel Blocker Sales, Revenue and Gross Margin (2015-2020)

12.10.4 Sanofi Calcium Channel Blocker Products Offered

12.10.5 Sanofi Recent Development

13 Calcium Channel Blocker Manufacturing Cost Analysis

13.1 Calcium Channel Blocker Key Raw Materials Analysis

13.1.1 Key Raw Materials

13.1.2 Key Raw Materials Price Trend

13.1.3 Key Suppliers of Raw Materials

13.2 Proportion of Manufacturing Cost Structure

13.3 Manufacturing Process Analysis of Calcium Channel Blocker

13.4 Calcium Channel Blocker Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

14.1 Marketing Channel

14.2 Calcium Channel Blocker Distributors List

14.3 Calcium Channel Blocker Customers

15 Market Dynamics

15.1 Market Trends

15.2 Opportunities and Drivers

15.3 Challenges

15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix

17.1 Research Methodology

17.1.1 Methodology/Research Approach

17.1.2 Data Source

17.2 Author List

17.3 Disclaimer

List of Tables

Table 1. Global Calcium Channel Blocker Sales (Kg) Growth Rate by Type (2020-2026)

Table 2. Global Calcium Channel Blocker Sales (Kg) Comparison by Application (2020-2026)

Table 3. COVID-19 Impact Global Market: (Four Calcium Channel Blocker Market Size Forecast Scenarios)

Table 4. Opportunities and Trends for Calcium Channel Blocker Players in the COVID-19 Landscape

Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 6. Key Regions/Countries Measures against Covid-19 Impact

Table 7. Proposal for Calcium Channel Blocker Players to Combat Covid-19 Impact

Table 8. Global Market Calcium Channel Blocker Market Size (US$ Million) by Region:2015 VS 2020 &2026

Table 9. Global Calcium Channel Blocker Sales (Kg) by Region (2015-2020)

Table 10. Global Calcium Channel Blocker Sales Market Share by Region (2015-2020)

Table 11. Global Calcium Channel Blocker Revenue (US$ Million) Market Share by Region (2015-2020))

Table 12. Global Calcium Channel Blocker Revenue Share by Region (2015-2020)

Table 13. Global Calcium Channel Blocker Sales (Kg) Forecast by Region (2021-2026)

Table 14. Global Calcium Channel Blocker Sales Market Share Forecast by Region (2021-2026)

Table 15. Global Calcium Channel Blocker Revenue (US$ Million) Forecast by Region (2021-2026)

Table 16. Global Calcium Channel Blocker Revenue Share Forecast by Region (2021-2026)

Table 17. Global Calcium Channel Blocker (Kg) of Key Companies (2015-2020)

Table 18. Global Calcium Channel Blocker Sales Share by Company (2015-2020)

Table 19. Global Calcium Channel Blocker Revenue (US$ Million) by Company (2015-2020)

Table 20. Global Calcium Channel Blocker Revenue Share by Company (2015-2020)

Table 21. Global Calcium Channel Blocker by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Calcium Channel Blocker as of 2019)

Table 22. Global Calcium Channel Blocker Average Price (USD/g) of Key Company (2015-2020)

Table 23. Manufacturers Calcium Channel Blocker Manufacturing Sites and Area Served

Table 24. Manufacturers Calcium Channel Blocker Product Type

Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 26. Main Points Interviewed from Key Calcium Channel Blocker Players

Table 27. Global Calcium Channel Blocker Sales (Kg) by Type (2015-2020)

Table 28. Global Calcium Channel Blocker Sales Share by Type (2015-2020)

Table 29. Global Calcium Channel Blocker Revenue (US$ Million) Market Share by Type (2015-2020)

Table 30. Global Calcium Channel Blocker Price (Kg) by Type (2015-2020)

Table 31. Global Calcium Channel Blocker Sales Share by Type (2021-2026)

Table 32. Global Calcium Channel Blocker Revenue (US$ Million) Market Share by Type (2021-2026)

Table 33. Global Calcium Channel Blocker Revenue Share by Type (2021-2026)

Table 34. Global Calcium Channel Blocker Price (Kg) by Type (2021-2026)

Table 35. Global Calcium Channel Blocker Sales (Kg) by Application (2015-2020)

Table 36. Global Calcium Channel Blocker Sales Share by Application (2015-2020)

Table 37. Global Calcium Channel Blocker Revenue (US$ Million) Market Share by Application (2015-2020)

Table 38. Global Calcium Channel Blocker Price (Kg) by Application (2015-2020)

Table 39. Global Calcium Channel Blocker Sales (Kg) by Application (2021-2026)

Table 40. Global Calcium Channel Blocker Sales Share by Application (2021-2026)

Table 41. Global Calcium Channel Blocker Revenue (US$ Million) Market Share by Application (2021-2026)

Table 42. Global Calcium Channel Blocker Revenue Share by Application (2021-2026)

Table 43. Global Calcium Channel Blocker Price (Kg) by Application (2021-2026)

Table 44. United States Calcium Channel Blocker Sales (Kg) by Company (2015-2020)

Table 45. United States Calcium Channel Blocker Sales Market Share by Company (2015-2020)

Table 46. United States Calcium Channel Blocker Sales (Kg) by Type (2015-2020)

Table 47. United States Calcium Channel Blocker Sales Market Share by Type (2015-2020)

Table 48. United States Calcium Channel Blocker Sales (Kg) by Application (2015-2020)

Table 49. United States Calcium Channel Blocker Sales Market Share by Application (2015-2020)

Table 50. Europe Calcium Channel Blocker Sales (Kg) by Company (2015-2020)

Table 51. Europe Calcium Channel Blocker Sales Market Share by Company (2015-2020)

Table 52. Europe Calcium Channel Blocker Sales (Kg) by Type (2015-2020)

Table 53. Europe Calcium Channel Blocker Sales Market Share by Type (2015-2020)

Table 54. Europe Calcium Channel Blocker Sales (Kg) by Application (2015-2020)

Table 55. Europe Calcium Channel Blocker Sales Market Share by Type (2015-2020)

Table 56. China Calcium Channel Blocker Sales (Kg) by Company (2015-2020)

Table 57. China Calcium Channel Blocker Sales Market Share by Company (2015-2020)

Table 58. China Calcium Channel Blocker Sales (Kg) by Type (2015-2020)

Table 59. China Calcium Channel Blocker Sales Market Share by Type (2015-2020)

Table 60. China Calcium Channel Blocker Sales (Kg) by Application (2015-2020)

Table 61. China Calcium Channel Blocker Sales Market Share by Application (2015-2020)

Table 62. Japan Calcium Channel Blocker Sales (Kg) by Company (2015-2020)

Table 63. Japan Calcium Channel Blocker Sales Market Share by Company (2015-2020)

Table 64. Japan Calcium Channel Blocker Sales (Kg) by Type (2015-2020)

Table 65. Japan Calcium Channel Blocker Sales Market Share by Type (2015-2020)

Table 66. Japan Calcium Channel Blocker Sales (Kg) by Application (2015-2020)

Table 67. Japan Calcium Channel Blocker Sales Market Share by Application (2015-2020)

Table 68. Southeast Asia Calcium Channel Blocker Sales (Kg) by Company (2015-2020)

Table 69. Southeast Asia Calcium Channel Blocker Sales Market Share by Company (2015-2020)

Table 70. Southeast Asia Calcium Channel Blocker Sales (Kg) by Type (2015-2020)

Table 71. Southeast Asia Calcium Channel Blocker Sales Market Share by Type (2015-2020)

Table 72. Southeast Asia Calcium Channel Blocker Sales (Kg) by Type (2015-2020)

Table 73. Southeast Asia Calcium Channel Blocker Sales Market Share by Application (2015-2020)

Table 74. India Calcium Channel Blocker Sales (Kg) by Company (2015-2020)

Table 75. India Calcium Channel Blocker Sales Market Share by Company (2015-2020)

Table 76. India Calcium Channel Blocker Sales (Kg) by Type (2015-2020)

Table 77. India Calcium Channel Blocker Sales Market Share by Type (2015-2020)

Table 78. India Calcium Channel Blocker Sales (Kg) by Application (2015-2020)

Table 79. India Calcium Channel Blocker Sales Market Share by Application (2015-2020)

Table 80. Pfizer Corporation Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer Calcium Channel Blocker Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table 83. Pfizer Calcium Channel Blocker Product

Table 84. Pfizer Recent Development

Table 85. Aventis Corporation Information

Table 86. Aventis Description and Business Overview

Table 87. Aventis Calcium Channel Blocker Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table 88. Aventis Calcium Channel Blocker Product

Table 89. Aventis Recent Development

Table 90. Searle Corporation Information

Table 91. Searle Description and Business Overview

Table 92. Searle Calcium Channel Blocker Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table 93. Searle Calcium Channel Blocker Product

Table 94. Searle Recent Development

Table 95. Bayer Corporation Information

Table 96. Bayer Description and Business Overview

Table 97. Bayer Calcium Channel Blocker Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table 98. Bayer Calcium Channel Blocker Product

Table 99. Bayer Recent Development

Table 100. AstraZeneca Corporation Information

Table 101. AstraZeneca Description and Business Overview

Table 102. AstraZeneca Calcium Channel Blocker Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table 103. AstraZeneca Calcium Channel Blocker Product

Table 104. AstraZeneca Recent Development

Table 105. Knoll Pharmaceuticals Corporation Information

Table 106. Knoll Pharmaceuticals Description and Business Overview

Table 107. Knoll Pharmaceuticals Calcium Channel Blocker Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table 108. Knoll Pharmaceuticals Calcium Channel Blocker Product

Table 109. Knoll Pharmaceuticals Recent Development

Table 110. Wyeth-Ayerst Corporation Information

Table 111. Wyeth-Ayerst Description and Business Overview

Table 112. Wyeth-Ayerst Calcium Channel Blocker Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table 113. Wyeth-Ayerst Calcium Channel Blocker Product

Table 114. Wyeth-Ayerst Recent Development

Table 115. AstraZeneca Corporation Information

Table 116. AstraZeneca Calcium Channel Blocker Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table 117. AstraZeneca Description and Business Overview

Table 118. AstraZeneca Calcium Channel Blocker Product

Table 119. AstraZeneca Recent Development

Table 120. Novartis Corporation Information

Table 121. Novartis Calcium Channel Blocker Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table 122. Novartis Description and Business Overview

Table 123. Novartis Calcium Channel Blocker Product

Table 124. Novartis Recent Development

Table . Sanofi Corporation Information

Table . Sanofi Description and Business Overview

Table . Sanofi Calcium Channel Blocker Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)

Table . Sanofi Calcium Channel Blocker Product

Table . Sanofi Recent Development

Table 130. Production Base and Market Concentration Rate of Raw Material

Table 131. Key Suppliers of Raw Materials

Table 132. Calcium Channel Blocker Distributors List

Table 133. Calcium Channel Blocker Customers List

Table 134. Market Key Trends

Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)

Table 136. Key Challenges

Table 137. Research Programs/Design for This Report

Table 138. Key Data Information from Secondary Sources

Table 139. Key Data Information from Primary Sources

List of Figures

Figure 1. Calcium Channel Blocker Product Picture

Figure 2. Global Calcium Channel Blocker Sales Market Share by Type in 2020 & 2026

Figure 3. Type I Product Picture

Figure 4. Type II Product Picture

Figure 5. Global Calcium Channel Blocker Market Share by Application in 2020 & 2026

Figure 6. Hypertension Examples

Figure 7. Coronary Artery Disease Examples

Figure 8. Arrhythmia Examples

Figure 9. Cardiomyopathy Examples

Figure 10. Global Calcium Channel Blocker Sales (Kg) Growth Rate (2015-2026)

Figure 11. Global Calcium Channel Blocker Revenue (US$ Million) Growth Rate (2015-2026)

Figure 12. Global Calcium Channel Blocker Price Trends Growth Rate (2015-2026) (USD/g)

Figure 13. Global Calcium Channel Blocker Revenue Market Share by Region: 2015 VS 2020

Figure 14. Global Calcium Channel Blocker Revenue Market Share by Region: 2021 VS 2026

Figure 15. United States Calcium Channel Blocker Revenue (Million USD) Growth Rate (2015-2026)

Figure 16. United States Calcium Channel Blocker Sales (Kg) Growth Rate (2015-2026)

Figure 17. Europe Calcium Channel Blocker Revenue (Million USD) Growth Rate (2015-2026)

Figure 18. Europe Calcium Channel Blocker Sales (Million USD) Growth Rate (2015-2026)

Figure 19. China Calcium Channel Blocker Revenue (Million USD) Growth Rate (2015-2026)

Figure 20. China Calcium Channel Blocker Sales (Million USD) and Growth Rate (2015-2026)

Figure 21. Japan Calcium Channel Blocker Revenue (Million USD) Growth Rate (2015-2026)

Figure 22. Japan Calcium Channel Blocker Sales (Million USD) Growth Rate (2015-2026)

Figure 23. Southeast Asia Calcium Channel Blocker Revenue (Million USD) Growth Rate (2015-2026)

Figure 24. Southeast Asia Calcium Channel Blocker Sales (Million USD) Growth Rate (2015-2026)

Figure 25. India Calcium Channel Blocker Revenue (Million USD) Growth Rate (2015-2026)

Figure 26. India Calcium Channel Blocker Sales (Million USD) Growth Rate (2015-2026)

Figure 27. Global 5 Largest Calcium Channel Blocker Players Market Share by Revenue in Calcium Channel Blocker 2015 & 2019

Figure 28. Calcium Channel Blocker Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 29. Global Calcium Channel Blocker Revenue Share by Type (2015-2020)

Figure 30. Global Calcium Channel Blocker Revenue Growth Rate by Type in 2015 & 2019

Figure 31. Global Calcium Channel Blocker Revenue Share by Application (2015-2020)

Figure 32. Global Calcium Channel Blocker Revenue Growth Rate by Application in 2015 & 2019

Figure 33. United States Calcium Channel Blocker Sales Market Share by Type in 2019

Figure 34. United States Calcium Channel Blocker Sales Market Share by Type in 2019

Figure 35. Europe Calcium Channel Blocker Sales Market Share by Company in 2019

Figure 36. Europe Calcium Channel Blocker Sales Market Share by Type in 2019

Figure 37. Europe Calcium Channel Blocker Sales Market Share by Application in 2019

Figure 38. China Calcium Channel Blocker Sales Market Share by Company in 2019

Figure 39. China Calcium Channel Blocker Sales Market Share by Type in 2019

Figure 40. China Calcium Channel Blocker Sales Market Share by Application in 2019

Figure 41. Japan Calcium Channel Blocker Sales Market Share by Company in 2019

Figure 42. Japan Calcium Channel Blocker Sales Market Share by Type in 2019

Figure 43. Japan Calcium Channel Blocker Sales Market Share by Application in 2019

Figure 44. Southeast Asia Calcium Channel Blocker Sales Market Share by Company in 2019

Figure 45. Southeast Asia Calcium Channel Blocker Sales Market Share by Type in 2019

Figure 46. Southeast Asia Calcium Channel Blocker Sales Market Share by Application in 2019

Figure 47. India Calcium Channel Blocker Sales Market Share by Company in 2019

Figure 48. India Calcium Channel Blocker Sales Market Share by Type in 2019

Figure 49. India Calcium Channel Blocker Sales Market Share by Application in 2019

Figure 50. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018

Figure 51. Aventis Total Revenue (US$ Million): 2019 Compared with 2018

Figure 52. Searle Total Revenue (US$ Million): 2019 Compared with 2018

Figure 53. Bayer Total Revenue (US$ Million): 2019 Compared with 2018

Figure 54. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018

Figure 55. Knoll Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 56. Wyeth-Ayerst Total Revenue (US$ Million): 2019 Compared with 2018

Figure 57. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018

Figure 58. Novartis Total Revenue (US$ Million): 2019 Compared with 2018

Figure 59. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018

Figure 60. Key Raw Materials Price Trend

Figure 61. Manufacturing Cost Structure of Calcium Channel Blocker

Figure 62. Manufacturing Process Analysis of Calcium Channel Blocker

Figure 63. Calcium Channel Blocker Industrial Chain Analysis

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

Figure 66. Porter's Five Forces Analysis

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

---